{"doi":"10.1002/pbc.25163","title":"Practices of pediatric oncology and hematology providers regarding fertility issues: A European survey","abstract":"<jats:sec><jats:title>Background</jats:title><jats:p>Fertility is impaired in many survivors of childhood cancer following treatment. Preservation of fertility after cancer has become a central survivorship concern. Nevertheless, several doctors, patients, and families do not discuss fertility and recommendations for fertility preservation in pediatrics are still lacking. Recommendations based on scientific evidence are needed and before their development we wanted to assess the practice patterns of fertility preservation in Europe.</jats:p></jats:sec><jats:sec><jats:title>Procedures</jats:title><jats:p>On behalf of the PanCare network, we sent a questionnaire to pediatric onco‐hematology institutions across Europe. The survey consisted of 21 questions assessing their usual practices around fertility preservation.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>One hundred ninety‐eight institutional representatives across Europe received the survey and 68 (response rate 34.3%) responded. Pre‐treatment fertility counseling was offered by 64 institutions. Counseling was done by a pediatric onco‐hematologist in 52% (33/64) and in 32% (20/64) by a team. The majority of institutions (53%) lacked recommendations for fertility preservation. All 64 centers offered sperm banking; eight offered testicular tissue cryopreservation for pre‐pubertal males. For females, the possibility of preserving ovarian tissue was offered by 40 institutions.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>There is a high level of interest in fertility preservation among European centers responding to our survey. However, while most recommended sperm cryopreservation, many also recommended technologies whose efficacy has not been shown. There is an urgent need for evidence‐based European recommendations for fertility preservation to help survivors deal with the stressful topic of fertility. Pediatr Blood Cancer 2014;61:2054–2058. © 2014 Wiley Periodicals, Inc.</jats:p></jats:sec>","journal":"Pediatric Blood &amp; Cancer","year":2014,"id":684128,"datarank":0.5416376868966337,"base_score":3.6109179126442243,"endowment":3.6109179126442243,"self_citation_contribution":0.5416376868966337,"citation_network_contribution":0.0,"self_endowment_contribution":0.5416376868966337,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":36,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":2,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1787245,"name":"Marco Spinelli","orcid":null,"position":1,"is_corresponding":false},{"id":1787246,"name":"Momcilo Jankovic","orcid":null,"position":2,"is_corresponding":false},{"id":1787247,"name":"Edit Bardi","orcid":null,"position":3,"is_corresponding":false},{"id":1113643,"name":"Lars Hjorth","orcid":"0000-0002-8302-7174","position":4,"is_corresponding":false},{"id":1787248,"name":"Riccardo Haupt","orcid":null,"position":5,"is_corresponding":false},{"id":851206,"name":"Gisela Michel","orcid":"0000-0002-9589-0928","position":6,"is_corresponding":false},{"id":917223,"name":"Julianne Byrne","orcid":"0000-0002-1070-3004","position":7,"is_corresponding":false},{"id":1787244,"name":"Monica Terenziani","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Practices of pediatric oncology and hematology providers regarding fertility issues: A European survey","abstract":"<jats:sec><jats:title>Background</jats:title><jats:p>Fertility is impaired in many survivors of childhood cancer following treatment. Preservation of fertility after cancer has become a central survivorship concern. Nevertheless, several doctors, patients, and families do not discuss fertility and recommendations for fertility preservation in pediatrics are still lacking. Recommendations based on scientific evidence are needed and before their development we wanted to assess the practice patterns of fertility preservation in Europe.</jats:p></jats:sec><jats:sec><jats:title>Procedures</jats:title><jats:p>On behalf of the PanCare network, we sent a questionnaire to pediatric onco‐hematology institutions across Europe. The survey consisted of 21 questions assessing their usual practices around fertility preservation.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>One hundred ninety‐eight institutional representatives across Europe received the survey and 68 (response rate 34.3%) responded. Pre‐treatment fertility counseling was offered by 64 institutions. Counseling was done by a pediatric onco‐hematologist in 52% (33/64) and in 32% (20/64) by a team. The majority of institutions (53%) lacked recommendations for fertility preservation. All 64 centers offered sperm banking; eight offered testicular tissue cryopreservation for pre‐pubertal males. For females, the possibility of preserving ovarian tissue was offered by 40 institutions.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>There is a high level of interest in fertility preservation among European centers responding to our survey. However, while most recommended sperm cryopreservation, many also recommended technologies whose efficacy has not been shown. There is an urgent need for evidence‐based European recommendations for fertility preservation to help survivors deal with the stressful topic of fertility. Pediatr Blood Cancer 2014;61:2054–2058. © 2014 Wiley Periodicals, Inc.</jats:p></jats:sec>","is_dataset_classified":null,"base_score":3.6109179126442243,"endowment":3.6109179126442243,"datacite_reuse_total":2,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"25065353","pmcid":null,"openalex_id":"https://openalex.org/W1897606800","authors":[],"funders":[{"funder_name":"European Commission","grant_id":"257505","title":"PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies"}],"total_grants":1,"fwci":5.3766,"citation_percentile":0.95538133,"influential_citations":0,"citation_trend":[{"year":2015,"count":5},{"year":2016,"count":8},{"year":2017,"count":4},{"year":2018,"count":3},{"year":2019,"count":2},{"year":2020,"count":2},{"year":2021,"count":4},{"year":2022,"count":1},{"year":2023,"count":2},{"year":2024,"count":1},{"year":2025,"count":3},{"year":2026,"count":1}],"oa_status":"closed","license":"Wiley Online Library User Agreement","oa_locations":[{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.25163","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.25163","host_type":"publisher"},{"url":"https://doi.org/10.1002/pbc.25163","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25065353","host_type":"repository"},{"url":"https://boris-portal.unibe.ch/handle/20.500.12422/125659","host_type":"repository"},{"url":"https://boris.unibe.ch/57562/","host_type":"repository"},{"url":"https://lup.lub.lu.se/record/4796286","host_type":"repository"},{"url":"https://dx.doi.org/10.7892/boris.57562","host_type":""},{"url":"https://dx.doi.org/10.1002/pbc.25163","host_type":""},{"url":"https://sonar.ch/global/documents/14870","host_type":""},{"url":"http://dx.doi.org/10.1002/pbc.25163","host_type":""}],"fields_of_study":["Reproductive Biology and Fertility","Sperm and Testicular Function","Reproductive Health and Technologies","03 medical and health sciences","0302 clinical medicine","Child","Counseling","Europe","Female","Fertility Preservation","Humans","Male","Neoplasms"],"mesh_terms":["Child","Counseling","Europe","Female","Humans","Male","Neoplasms","Fertility Preservation"],"keywords":["Fertility","Fertility preservation","Medicine","Oncofertility","Family medicine","Sperm bank","Survivorship curve","Reproductive medicine","Ovarian tissue cryopreservation","Gynecology","Cancer","Internal medicine","Pregnancy","Environmental health","Population","Biology","Counseling","Male","Hematology","Europe","Oncology","Neoplasms","Humans","Female","Pediatrics, Perinatology, and Child Health","Child","childhood cancer survivors","survey"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.12082212.v1","title":"Additional file 1 of Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12082212","title":"Additional file 1 of Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-18T13:22:22.074592Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}